Washed Microbiota Transplantation for Tourette's Syndrome

Sponsor
The Second Hospital of Nanjing Medical University
Study ID
NCT03764748
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
6 Years - 17 Years
Healthy Volunteers
Accepted

Interventions

  • Washed Microbiota Transplantation — DRUG
    The prepared microbiota suspension was infused into the participates' lower gut.

Study Details

This study aimed to evaluate the efficacy of washed microbiota transplantation in the treatment of Tourette's syndrome (TS).

Key Dates

Start date
Apr 17, 2024
Status verified
Aug 2024
Primary completion
Oct 31, 2027
Completion
Oct 31, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Washed microbiota transplantation
    WMT

Primary Outcome Measure

The change of Yale Global Tic Severity Scale-Total Tic Score (YGTSS-TTS) [ Time Frame: baseline, 4 weeks, 8 weeks, 12 weeks, 6 months post transplantation ]

Central Contacts

Related Studies